Ataxia‐Telangiectasia Mutated Kinase: A Potential New Target for Suppressing Inflammation in Heart Failure?
Open Access
- 17 December 2014
- journal article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 3 (6) , e001591
Abstract
Journal of the American Heart Association (JAHA) is an authoritative, peer-reviewed Open Access journal focusing on cardiovascular and cerebrovascular diseaseKeywords
This publication has 24 references indexed in Scilit:
- Mechanisms and Functions of InflammasomesCell, 2014
- Deficiency of Ataxia Telangiectasia Mutated Kinase Modulates Cardiac Remodeling Following Myocardial Infarction: Involvement in Fibrosis and ApoptosisPLOS ONE, 2013
- Cell death in the myocardium: My heart won't go onIUBMB Life, 2013
- Regulator of G Protein Signaling 6 Mediates Doxorubicin-Induced ATM and p53 Activation by a Reactive Oxygen Species–Dependent MechanismCancer Research, 2011
- In search of new therapeutic targets and strategies for heart failure: recent advances in basic scienceThe Lancet, 2011
- Programmed Necrosis, Not Apoptosis, in the HeartCirculation Research, 2011
- The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relaxDNA Repair, 2010
- ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 InhibitorsMolecular Cancer Therapeutics, 2010
- Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodellingCardiovascular Research, 2008
- Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.Circulation, 1987